{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:49:03Z","timestamp":1792662543677,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015R1D1A1A01060056"],"award-info":[{"award-number":["2015R1D1A1A01060056"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016M3C7A1914002"],"award-info":[{"award-number":["2016M3C7A1914002"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.nbd.2021.105374","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T12:27:48Z","timestamp":1619785668000},"page":"105374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Exosomes as a potential messenger unit during heterochronic parabiosis for amelioration of Huntington's disease"],"prefix":"10.1016","volume":"155","author":[{"given":"Mijung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wooseok","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2021.105374_bb0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1570159X14666160825160421","article-title":"Exosomes: the messengers of health and disease","volume":"15","author":"Allison","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.nbd.2021.105374_bb0010","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/mds.26020","article-title":"Huntingtin-lowering strategies in Huntington\u2019s disease: antisense oligonucleotides, small RNAs, and gene editing","volume":"29","author":"Aronin","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105374_bb0015","doi-asserted-by":"crossref","first-page":"15,005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.nbd.2021.105374_bb0020","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/prca.201400114","article-title":"Exosomes in bodily fluids are a highly stable resource of disease biomarkers","volume":"9","author":"Boukouris","year":"2015","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.nbd.2021.105374_bb0025","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/hep4.1066","article-title":"Increased ethanol-inducible cytochrome P450-2E1 and cytochrome P450 isoforms in exosomes of alcohol-exposed rodents and patients with alcoholism through oxidative and endoplasmic reticulum stress","volume":"1","author":"Cho","year":"2017","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.nbd.2021.105374_bb0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.molmed.2018.01.006","article-title":"Manufacturing exosomes: a promising therapeutic platform","volume":"24","author":"Colao","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2021.105374_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2015.00361","article-title":"Cognitive training at a young age attenuates deficits in the zQ175 mouse model of HD","volume":"9","author":"Curtin","year":"2016","journal-title":"Front. Behav. Neurosci."},{"issue":"41","key":"10.1016\/j.nbd.2021.105374_bb0040","first-page":"316","article-title":"Impairment of blood-brain barrier is an early event in R6\/2 mouse model of Huntington Disease","volume":"7","author":"Di Pardo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2021.105374_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2005.01.024","article-title":"Early behavioral deficits in R6\/2 mice suitable for use in preclinical drug testing","volume":"20","author":"Hickey","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105374_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2015.00106","article-title":"The male sex pheromone darcin stimulates hippocampal neurogenesis and cell proliferation in the subventricular zone in female mice","volume":"9","author":"Hoffman","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.nbd.2021.105374_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059438","article-title":"Extracts of adipose derived stem cells slows progression in the R6\/2 model of Huntington's disease","volume":"8","author":"Im","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2021.105374_bb0060","doi-asserted-by":"crossref","first-page":"16,887","DOI":"10.1038\/srep16887","article-title":"Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington\u2019s disease R6\/2 model","volume":"5","author":"Im","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2021.105374_bb0065","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.bbamem.2016.02.011","article-title":"Exosomes and other extracellular vesicles in neural cells and neurodegenerative diseases","volume":"1858","author":"Janas","year":"2016","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.nbd.2021.105374_bb0070","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12035-013-8544-1","article-title":"Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics","volume":"49","author":"Kalani","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2021.105374_bb0075","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2021.105374_bb0080","article-title":"Young systemic factors as a medicine for age-related neurodegenerative diseases","volume":"2","author":"Katsimpardi","year":"2015","journal-title":"Neurogenesis (Austin)"},{"key":"10.1016\/j.nbd.2021.105374_bb0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.imlet.2006.09.005","article-title":"Exosomes: from biogenesis and secretion to biological function","volume":"107","author":"Keller","year":"2006","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.nbd.2021.105374_bb0090","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1021\/cn500100r","article-title":"Astrocytes and Huntington\u2019s disease","volume":"5","author":"Khakh","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2021.105374_bb0095","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/mds.27363","article-title":"Huntington's disease: Current and future therapeutic prospects","volume":"33","author":"Kieburtz","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105374_bb0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12257-015-0781-x","article-title":"Influence of storage condition on exosome recovery","volume":"21","author":"Lee","year":"2016","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"10.1016\/j.nbd.2021.105374_bb0105","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbrc.2016.09.069","article-title":"Adipose-derived stem cell exosomes alleviate pathology of amyotrophic lateral sclerosis in vitro","volume":"479","author":"Lee","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2021.105374_bb0110","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1111\/ejn.13275","article-title":"Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington's disease in vitro model","volume":"44","author":"Lee","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2021.105374_bb0115","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","article-title":"The use of the R6 transgenic mouse models of Huntington\u2019s disease in attempts to develop novel therapeutic strategies","volume":"2","author":"Li","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.nbd.2021.105374_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biocel.2011.10.005","article-title":"Exosomes: small vesicles participating in intercellular communication","volume":"44","author":"Ludwig","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.nbd.2021.105374_bb0125","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG Repeat Is Sufficient To Cause A Progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell."},{"key":"10.1016\/j.nbd.2021.105374_bb0130","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/mds.26006","article-title":"Animal models of Huntington's disease for translation to the clinic: Best practices","volume":"29","author":"Menalled","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2021.105374_bb0135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2021.105374_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049838","article-title":"Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington\u2019s Disease: zQ175","volume":"7","author":"Menalled","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2021.105374_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099520","article-title":"Genetic deletion of transglutaminase 2 does not rescue the phenotypic deficits observed in R6\/2 and zQ175 mouse models of Huntington\u2019s disease","volume":"9","author":"Menalled","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2021.105374_bb0150","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jamaneurol.2016.3185","article-title":"Preclinical Assessment of Young Blood Plasma for Alzheimer\u2019s disease","volume":"73","author":"Middeldorp","year":"2016","journal-title":"JAMA Neurol."},{"issue":"34","key":"10.1016\/j.nbd.2021.105374_bb2000","doi-asserted-by":"crossref","first-page":"35263","DOI":"10.18632\/oncotarget.5894","article-title":"RAGE mediated intracellular A\u03b2 uptake contributes to the breakdown of tight junction in retinal pigment epithelium","volume":"6","author":"Park","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.nbd.2021.105374_bb0155","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.drudis.2014.03.020","article-title":"Increased mitochondrial fission and neuronal dysfunction in Huntington\u2019s disease: implications for molecular inhibitors of excessive mitochondrial fission","volume":"19","author":"Reddy","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.nbd.2021.105374_bb0160","article-title":"Shedding a new light on Huntington\u2019s disease: how blood can both propagate and ameliorate disease pathology","author":"Rieux","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2021.105374_bb0165","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2021.105374_bb0170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejmech.2013.09.050","article-title":"Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection","volume":"70","author":"Singh","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.nbd.2021.105374_bb0175","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/hmg\/ddu010","article-title":"A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington\u2019s disease","volume":"23","author":"Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2021.105374_bb0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2021.105374_bb0185","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nm.3569","article-title":"Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice","volume":"20","author":"Villeda","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2021.105374_bb0190","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nature20411","article-title":"Ageing, neurodegeneration and brain rejuvenation","volume":"539","author":"Wyss-Coray","year":"2016","journal-title":"Nature."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121001236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996121001236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:26:39Z","timestamp":1760851599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996121001236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":39,"alternative-id":["S0969996121001236"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105374","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomes as a potential messenger unit during heterochronic parabiosis for amelioration of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2021.105374","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105374"}}